• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

横纹肌肉瘤的分子与细胞生物学。

Molecular and cellular biology of rhabdomyosarcoma.

机构信息

Department of Experimental Pathology, Cancer Research Section, University of Bologna, Bologna, Italy.

出版信息

Future Oncol. 2009 Nov;5(9):1449-75. doi: 10.2217/fon.09.97.

DOI:10.2217/fon.09.97
PMID:19903072
Abstract

Rhabdomyosarcoma is a group of soft-tissue sarcomas that share features of skeletal myogenesis, but show extensive heterogeneity in histology, age and site of onset, and prognosis. This review matches recent molecular data with biological features of rhabdomyosarcoma. Alterations in molecular pathways, animal models, cell of origin and potential new therapeutic targets are discussed.

摘要

横纹肌肉瘤是一组软组织肉瘤,具有骨骼肌发生的特征,但在组织学、发病年龄和部位以及预后方面存在广泛的异质性。本综述将最新的分子数据与横纹肌肉瘤的生物学特征相匹配。讨论了分子途径、动物模型、起源细胞和潜在新治疗靶点的改变。

相似文献

1
Molecular and cellular biology of rhabdomyosarcoma.横纹肌肉瘤的分子与细胞生物学。
Future Oncol. 2009 Nov;5(9):1449-75. doi: 10.2217/fon.09.97.
2
Prognostic factors in childhood rhabdomyosarcoma.儿童横纹肌肉瘤的预后因素
Lancet. 1989 Oct 21;2(8669):959-60.
3
Muscling in on rhabdomyosarcoma.侵入横纹肌肉瘤
Nat Med. 2002 Nov;8(11):1200-1. doi: 10.1038/nm1102-1200.
4
Rhabdomyosarcoma and other soft tissue sarcomas of childhood.儿童横纹肌肉瘤及其他软组织肉瘤
Curr Opin Oncol. 1991 Aug;3(4):677-83.
5
Rhabdomyosarcomas and other soft tissue sarcomas in pediatric patients.小儿患者的横纹肌肉瘤及其他软组织肉瘤
Curr Opin Oncol. 1993 Jul;5(4):672-7. doi: 10.1097/00001622-199307000-00010.
6
Rhabdomyosarcoma and other soft tissue sarcomas of childhood.儿童横纹肌肉瘤及其他软组织肉瘤
Curr Opin Oncol. 1994 Jul;6(4):397-402. doi: 10.1097/00001622-199407000-00012.
7
Pediatric soft tissue sarcomas.小儿软组织肉瘤
Curr Opin Oncol. 1990 Jun;2(3):481-5.
8
Extremity rhabdomyosarcoma: biological principles, staging, and treatment.肢体横纹肌肉瘤:生物学原理、分期及治疗
Semin Surg Oncol. 1993 Nov-Dec;9(6):510-9. doi: 10.1002/ssu.2980090609.
9
Pediatric solid tumors II: Rhabdomyosarcoma.小儿实体瘤II:横纹肌肉瘤。
Ariz Med. 1981 Mar;38(3):188-90.
10
Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma.不可切除横纹肌肉瘤患儿及青少年的肿瘤细胞倍性与组织学亚型及治疗结果的关系
J Clin Oncol. 1991 Jan;9(1):159-66. doi: 10.1200/JCO.1991.9.1.159.

引用本文的文献

1
Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma.磷脂酰肌醇蛋白聚糖3作为预防横纹肌肉瘤细胞迁移和增殖的靶向治疗。
Sci Rep. 2025 Jul 1;15(1):20913. doi: 10.1038/s41598-025-03466-x.
2
Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.肺泡横纹肌肉瘤的分子靶点:进展与陷阱的叙述性综述
Int J Mol Sci. 2025 May 28;26(11):5204. doi: 10.3390/ijms26115204.
3
Alveolar Rhabdomyosarcoma of the Temporal Region with Metastatic Cervical Lymph Node.颞部肺泡状横纹肌肉瘤伴颈部转移性淋巴结
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):1075-1079. doi: 10.1007/s12070-023-04120-6. Epub 2023 Aug 10.
4
Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.软组织肉瘤中的小型非编码 RNA:现状与未来方向。
Mol Cancer Res. 2023 Jun 1;21(6):511-524. doi: 10.1158/1541-7786.MCR-22-1008.
5
High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.融合阳性横纹肌肉瘤中肿瘤起始细胞的高频。
Genes (Basel). 2021 Aug 31;12(9):1373. doi: 10.3390/genes12091373.
6
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy.HER 酪氨酸激酶家族与横纹肌肉瘤:发病机制与靶向治疗中的作用。
Cells. 2021 Jul 16;10(7):1808. doi: 10.3390/cells10071808.
7
Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity.利用原发性横纹肌肉瘤的活体生物库进行表型分析,揭示了疾病异质性和 AKT 敏感性。
Nat Commun. 2020 Sep 15;11(1):4629. doi: 10.1038/s41467-020-18388-7.
8
Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.用化疗药物与 BH3 模拟物的序贯联合治疗横纹肌肉瘤并避免耐药。
Cell Death Dis. 2020 Aug 15;11(8):634. doi: 10.1038/s41419-020-02887-y.
9
NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.NuRD 亚基 CHD4 调节横纹肌肉瘤中超增强子的可及性,并代表一种普遍的肿瘤依赖性。
Elife. 2020 Aug 3;9:e54993. doi: 10.7554/eLife.54993.
10
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R.共同靶向HER2/Neu和IGF1R的癌症疫苗
Cancers (Basel). 2019 Apr 11;11(4):517. doi: 10.3390/cancers11040517.